Jean‐Claude Bordet

Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer

Ahmed Boucharaba, Claire‐Marie Serre, Sandra Grès et al. · Journal of Clinical Investigation · 2004 · 410 citations · Full text

Medicine, Cancer Biology, Oncology +15

Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer

Ahmed Boucharaba, Claire‐Marie Serre, Sandra Grès et al. · Journal of Clinical Investigation · 2004 · 388 citations · Full text

Medicine, Cancer Biology, Oncology +15

Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B

Suzette Beguı́n, Anne Lienhart, Raed Al Dieri et al. · Thrombosis and Haemostasis · 2005 · 333 citations · Full text

Medicine, Hematology, Hematology Physiology +16

Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions

M Levade, Elodie David, Cédric Garcia et al. · Blood · 2014 · 312 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases

Ahmed Boucharaba, Claire‐Marie Serre, Julien Guglielmi et al. · Proceedings of the National Academy of Sciences · 2006 · 208 citations · Full text

Medicine, Oncology, Pharmacology +17